Non-alcoholic fatty liver disease Noninvasive scores

Revision as of 15:45, 22 August 2023 by Badgettrg (talk | contribs)
Jump to navigation Jump to search

Non-Alcoholic Fatty Liver Disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Non-alcoholic fatty liver disease Noninvasive scores On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-alcoholic fatty liver disease Noninvasive scores

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-alcoholic fatty liver disease Noninvasive scores

CDC on Non-alcoholic fatty liver disease Noninvasive scores

Non-alcoholic fatty liver disease Noninvasive scores in the news

Blogs on Non-alcoholic fatty liver disease Noninvasive scores

Directions to Hospitals Treating Non-alcoholic fatty liver disease

Risk calculators and risk factors for Non-alcoholic fatty liver disease Noninvasive scores

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

FIB-4 index at MedCalc and https://www.hepatitisc.uw.edu/page/clinical-calculators/fib-4 . For assessing need for biopsy in hepatitis B and hepatitis C.

NAFLD fibrosis score MedCalc APRI MedCalc

The LiverRisk score *https://www.liverriskscore.com/) may be more accurate than the FIB-4 or aspartate transferase to platelet ratio index (APRI) at repdicting liver stiffness measurements of 6 kPa or more, 10 kPa or more, and 15 kPa[1]. These kPa thresholds correspond to:

  • 6 kPa: no fibrosis
  • 10 kPa: between F3 and F4 fibrosis
  • 15 kPa: above F4 fibrosis

"LS of 8 and 12.5 kPa represent generally accepted cut-off values for F3 and F4 fibrosis. LS highly correlates with portal pressure, and esophageal varices are likely at values >20 kPa."[2]

A newer score is the NAFLD-MESA Index[3]


References

  1. Serra-Burriel M, Juanola A, Serra-Burriel F, Thiele M, Graupera I, Pose E; et al. (2023). "Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study". Lancet. doi:10.1016/S0140-6736(23)01174-1. PMID 37572680 Check |pmid= value (help).
  2. Mueller S, Sandrin L (2010). "Liver stiffness: a novel parameter for the diagnosis of liver disease". Hepat Med. 2: 49–67. doi:10.2147/hmer.s7394. PMC 3846375. PMID 24367208.
  3. Rodriguez, L.A., Shiboski, S.C., Bradshaw, P.T. et al. Predicting Non-Alcoholic Fatty Liver Disease for Adults Using Practical Clinical Measures: Evidence from the Multi-ethnic Study of Atherosclerosis. J GEN INTERN MED 36, 2648–2655 (2021). https://doi.org/10.1007/s11606-020-06426-5

Template:WS Template:WH